<DOC>
	<DOCNO>NCT00218049</DOCNO>
	<brief_summary>Cocaine dependence major public health problem ; effective primary treatment cocaine dependent individual yet find . The purpose study determine safety effect vanoxerine ( GBR 12909 ) treat cocaine dependent individual .</brief_summary>
	<brief_title>Interaction Between Vanoxerine ( GBR 12909 ) Cocaine Cocaine Dependent Individuals</brief_title>
	<detailed_description>Cocaine strong central nervous system stimulant widely abuse throughout United Sates . Due widespread use , important develop effective treatment cocaine dependence . Dopamine transporter ( DAT ) play important role addictive nature cocaine ; use compound target DAT may effective treat cocaine dependent individual . Research show GBR 12909 strong affinity DAT . The purpose study determine safety potential interaction GBR 12909 cocaine cocaine dependent individual .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Vanoxerine</mesh_term>
	<criteria>Meets DSMIV criterion current cocaine dependence Not currently seek treatment cocaine dependence Currently use cocaine , determine selfreport positive urine test cocaine , within 30 day prior study entry Within 20 % ideal body weight , weigh least 100 lbs Good general health Normal electrocardiogram Willing use acceptable method contraception duration study Current history major psychiatric illness , drug dependence disorder secondary drug abuse Meets DSMIV criterion dependence drug cocaine , marijuana , nicotine , alcohol Physiologically dependent alcohol require medical detoxification Use prescription drug within 14 day prior study entry Use nonprescription drug within 7 day prior study entry If female , used oral contraceptive , DepoProvera , Norplant , intrauterine progesterone contraceptive system , within 30 day prior study entry Pregnant breastfeed History liver disease Current elevate aspartate aminotransferase alanine aminotransferase level Donated unit blood within 4 week prior study entry Participated clinical investigation within 4 week prior study entry History illness behavior , opinion investigator , might interfere study Family history early significant cardiovascular disease Exhibits Hepatitis B surface antigen Hepatitis C antibody HIV infect Syphilis Active tuberculosis Adult asthma Chronic obstructive pulmonary disease Unable distinguish 20 mg 40 mg intravenous cocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>